Anthem Biosciences IPO: A Comprehensive Review and Analysis
Anthem Biosciences Limited, a Contract Research, Development, and Manufacturing Organization (CRDMO), has hit the Indian primary market with its initial public offering (IPO) on Monday, July 14. The public issue will remain open until 16 July 2025, aiming to raise ₹3,395 crore from this entirely offer-for-sale (OFS) issue.
